Analysis of clinical characteristics of procadherin 19 gene mutation associated epilepsy

DUAN Yuanhui; CAO Jie

doi:10.7619/jcmp.20200657

Journal of Clinical Medicine in Practice > 2021 > 25(3): 28-32. > DOI: 10.7619/jcmp.20200657

DUAN Yuanhui, CAO Jie. Analysis of clinical characteristics of procadherin 19 gene mutation associated epilepsy[J]. Journal of Clinical Medicine in Practice, 2021, 25(3): 28-32. DOI: 10.7619/jcmp.20200657

Citation:

PDF (1135 KB)

Analysis of clinical characteristics of procadherin 19 gene mutation associated epilepsy

DUAN Yuanhui,
CAO Jie^,

Department of General Medicine, Children′s Hospital Affiliated to Chongqing Medical University, National Clinical Research Centre for Child Health, Chongqing, 400010

More Information

Received Date: August 29, 2020
Available Online: March 03, 2021
Published Date: March 03, 2021

Graphical Abstract

Abstract

Abstract

Objective To analyze the clinical features and prognosis of epilepsy caused by protocadherin 19 (PCDH19) gene mutation.
Methods The clinical data of two children with epilepsy caused by PCDH19 gene mutation was retrospectively analyzed, and their clinical characteristics were analyzed in according to relevant literatures and clinical data in combination.
Results Both of the two children were female, with retarded language development and no fever. Antiepileptic drugs were effective of two children. Gene sequencing indicated that PCDH19 gene was a novel mutation in two children.
Conclusion PCDH19 gene mutations can be inherited from parents or novel mutations, and the onset of epilepsy caused by PCDH19 is usually in infancy, mostly in female. After puberty, the frequency of seizures decreas in patients, but no significant improvement in their intelligence is found.
- epilepsy,
- protocadherin 19,
- mutation,
- gene sequencing

FullText(HTML)

References (19)

References

[1]	JUBERG R C, HELLMAN C D. A new familial form of convulsive disorder and mental retardation limited to females[J]. J Pediatr, 1971, 79(5): 726-732. doi: 10.1016/S0022-3476(71)80382-7
[2]	DIBBENS L M, TARPEY P S, HYNES K, et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment[J]. Nat Genet, 2008, 40(6): 776-781. doi: 10.1038/ng.149
[3]	刘爱杰, 许小菁, 孙丹, 等. 原钙黏蛋白19基因相关癫痫的遗传特点及临床表型谱研究[J]. 癫痫杂志, 2017, 3(4): 283-291. https://www.cnki.com.cn/Article/CJFDTOTAL-DXZA201704002.htm
[4]	PEDERICK D T, RICHARDS K L, PILTZ S G, et al. Abnormal cell sorting underlies the unique X-linked inheritance of PCDH19 epilepsy[J]. Neuron, 2018, 97(1): 59-66. e5. doi: 10.1016/j.neuron.2017.12.005
[5]	KIM S Y, YASUDA S, TANAKA H, et al. Non-clustered protocadherin[J]. Cell Adhesion Migr, 2011, 5(2): 97-105. doi: 10.4161/cam.5.2.14374
[6]	KOLC K L, SADLEIR L G, SCHEFFER I E, et al. A systematic review and meta-analysis of 271 PCDH19-variant individuals identifies psychiatric comorbidities, and association of seizure onset and disease severity[J]. Mol Psychiatry, 2019, 24(2): 241-251. doi: 10.1038/s41380-018-0066-9
[7]	LIGHT S E W, JONTES J D. Multiplane calcium imaging reveals disrupted development of network topology in zebrafish pcdh19 mutants[J]. eNeuro, 2019, 6(3): 371-375. http://www.researchgate.net/publication/332917982_Multiplane_Calcium_Imaging_Reveals_Disrupted_Development_of_Network_Topology_in_Zebrafish_pcdh19_Mutants
[8]	HERTEL N, REDIES C. Absence of layer-specific cadherin expression profiles in the neocortex of the reeler mutant mouse[J]. Cereb Cortex, 2011, 21(5): 1105-1117. doi: 10.1093/cercor/bhq183
[9]	DUSZYC K, TERCZYNSKA I, HOFFMAN-ZACHARSKA D. Epilepsy and mental retardation restricted to females: X-linked epileptic infantile encephalopathy of unusual inheritance[J]. J Appl Genet, 2015, 56(1): 49-56. doi: 10.1007/s13353-014-0243-8
[10]	YANG L, LIU J, SU Q, et al. Novel and de novo mutation of PCDH19 in Girls Clustering Epilepsy[J]. Brain Behav, 2019, 9(12): e01455. doi: 10.1002/brb3.1455
[11]	NIAZI R, FANNING E A, DEPIENNE C, et al. A mutation update for the PCDH19 gene causing early-onset epilepsy in females with an unusual expression pattern[J]. Hum Mutat, 2019, 40(3): 243-257. doi: 10.1002/humu.23701
[12]	ROMASKO E J, DECHENE E T, BALCIUNIENE J, et al. PCDH19-related epilepsy in a male with Klinefelter syndrome: Additional evidence supporting PCDH19 cellular interference disease mechanism[J]. Epilepsy Res, 2018, 145: 89-92. doi: 10.1016/j.eplepsyres.2018.06.008
[13]	TRIVISANO M, PIETRAFUSA N, CIOMMO V D, et al. PCDH19-related epilepsy and Dravet Syndrome: Face-off between two early-onset epilepsies with fever sensitivity[J]. Epilepsy Res, 2016, 125: 32-36. doi: 10.1016/j.eplepsyres.2016.05.015
[14]	SHMUELY S, SISODIYA S M, GUNNING W B, et al. Mortality in Dravet syndrome: a review[J]. Epilepsy Behav, 2016, 64: 69-74. doi: 10.1016/j.yebeh.2016.09.007
[15]	张赟健, 周水珍. 早发性癫痫性脑病基因突变研究与诊治[J]. 中国实用儿科杂志, 2015, 30(7): 492-497.
[16]	TRIVISANO M, SPECCHIO N. The role of PCDH19 in refractory status epilepticus[J]. Epilepsy Behav, 2019, 101 (Pt B): 106539. http://www.sciencedirect.com/science/article/pii/S1525505019308534
[17]	TAN C, SHARD C, RANIERI E, et al. Mutations of protocadherin 19 in female epilepsy (PCDH19-FE) lead to allopregnanolone deficiency[J]. Hum Mol Genet, 2015, 24(18): 5250-5259. doi: 10.1093/hmg/ddv245
[18]	DEPIENNE C, TROUILLARD O, BOUTEILLER D, et al. Mutations and deletions in PCDH19 account for various familial or isolated epilepsies in females[J]. Hum Mutat, 2011, 32(1): E1959-E1975. doi: 10.1002/humu.21373
[19]	TRIVISANO M, PIETRAFUSA N, TERRACCIANO A, et al. Defining the electroclinical phenotype and outcome of PCDH19-related epilepsy: a multicenter study[J]. Epilepsia, 2018, 59(12): 2260-2271. doi: 10.1111/epi.14600

Cited By

Get Citation

PDF

XML

Article views PDF downloads

Turn off MathJax

Article Contents

Abstract

References

Analysis of clinical characteristics of procadherin 19 gene mutation associated epilepsy

Abstract

References

Catalog

Export File

Citation

Format

Content